Testing a blood-filter treatment in children with early sepsis
Part of Infections clinical trials.
This trial looks at whether a blood-filter treatment (called “AN69ST Verse PS” using a hemofilter) can help children with early, serious sepsis and poor circulation or organ problems. It may help stabilize the body faster, but eligibility is limited to certain sepsis situations and recent timing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Child is between 29 days old and 18 years old
- Doctor diagnosis of sepsis within the last 48 hours
- Sepsis is severe: it affects more than one organ, causes poor blood flow to tissues, or has septic shock
- Consent must be available from the child’s parent/guardian or legal representative
- Child must NOT be on chronic dialysis for end-stage kidney disease
- Child must not have certain safety concerns (for example: heparin allergy or prior heparin-related low platelets)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a blood purification treatment can help children with severe sepsis (a life-threatening infection) by filtering their blood to remove harmful substances. It may help improve organ function and recovery.
This trial tests a blood-filtering treatment for people in septic shock, a severe reaction to infection. It aims to see if removing harmful substances from the blood can help recovery.
This trial tests a special blood filter called Oxiris that may help remove toxins and inflammation from the blood in patients with septic shock. It aims to see if this treatment can improve outcomes for people who need kidney replacement therapy.
This trial tests if a special blood-filtering method combined with plasma exchange can help people with severe liver failure and sepsis. It aims to reduce inflammation and improve survival.
This trial tests a new treatment to protect and repair the layer of cells lining your blood vessels (glycocalyx) during sepsis. It aims to improve recovery from severe infections.
This study tests a blood-cleaning treatment to remove harmful toxins from the blood of people with severe abdominal infections. It might help their organs recover faster.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.